Metabolix, Inc. To Present at Piper Jaffray Consumer Conference
640519
Metabolix, Inc. (NASDAQ: MBLX), a company developing and commercializing  environmentally sustainable and totally biodegradable MirelTM  natural plastic, today announced that it will be presenting  at the Piper Jaffray & Co. Consumer Conference taking place on June 6 --  7,2007 in New York City.
768157
Biogen presents at the JPMorgan Healthcare Conference.
153875
BOSTON, Oct. 29 /PRNewswire/ -- Data to be presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) demonstrated that treatment with the Bristol-Myers Squibb
258313
Merck (nyse: MRK - news - people ) will conduct its annual analyst meeting tomorrow. The drug company is expected to provide information regarding liabilities for potential Vioxx-related lawsuits.
704846
Celanese Corporation (NYSE:CE), a global hybrid chemical company, today announced that David N. Weidman, president and chief executive officer, will address investors at the Bank of America 36th Annual Investment Conference on Monday, September 18 at 2:00 p.m. Pacific Time in San Francisco.
645194
Join Lora Cecere, Research Director, AMR Research and Dr. Amit Shekhar, Global Head- Supply Chain Management, HCL Technologies for this on demand webcast as they discuss trends in Supply Chain and how demand driven retailing is bringing in tangible benefits to retailers.
733063
The University of Massachusetts Lowell announced a licensing agreement  with Metabolix Inc. (www.metabolix.com)  for the production of improved high performance plastics that are  biobased, sustainable and biodegradable.  The material method (US Patent No.
161580
Britain&#39;s GW Pharmaceuticals Plc said on  Tuesday its pioneering cannabis-based drug Sativex had  qualified to be considered for approval by Canadian regulators  as a treatment for cancer pain.
667475
Greenstone Holdings, Inc. (PINKSHEETS: GSHG) announced today that the Company will introduce its chemical product GreenShield(TM) to the industry, including potential customers, at the International Builders' Show ("IBS") in Orlando, FL this week.
635340
Shares of CoTherix Inc.  rose 2.7 percent  before the bell on Tuesday after Piper Jaffray initiated coverage of the biopharmaceutical company with an "outperform" rating and a &#36;10 price target.
623767
Metabolic Pharmaceuticals, an Australian biotech group announced Monday that its new weight-loss drug, known as AOD9604 appears to help overweight people to burn fat and does not have any apparent side effects.
676409
As part of our ongoing technology education webcast series, Cisco Systems (NASDAQ: CSCO) will host a webcast with a corresponding slide presentation on Tuesday, May 29 at 1:30PM Pacific to discuss Cisco's newly announced integrated Mobility Solutions.
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
419002
Jillian Elliott, president of Foresight Nanotech Institute, the leading think tank and public interest organization focused on nanotechnology, will speak on the International Technology Roadmap for Productive Nanosystems at nanoTX '06 on September 27, 2006 at 10:30 a.m.
511019
Microsoft head honcho expected to use the spotlight at the Consumer Electronics Show to talk Xbox 2. The Consumer Electronics Association today announced the keynote speakers for the International Consumer
409761
Genzyme shows some sparkle at investors' conference.
623395
Biogen Idec Inc. of Cambridge said it is in final discussions with the Food and Drug Administration about its new multiple sclerosis drug Antegren, and expects the drug to be approved by the end of the month.